University of Texas at Dallas - Quantitative Biomedical Research Center, University of Texas at Dallas - Quantitative Biomedical Research Center, University of Texas at Dallas - Quantitative Biomedical Research Center, University of Texas at Dallas - Quantitative Biomedical Research Center, University of Texas at Dallas - Department of Urology, University of Texas at Houston - Department of Genitourinary Medical Oncology, University of Texas at Dallas - Department of Radiation Oncology, University of Texas at Dallas - Department of Radiation Oncology, University of Texas at Dallas - Quantitative Biomedical Research Center, University of Texas at Dallas - Department of Pathology, University of Texas at Dallas - Center for the Genetics of Host Defense, University of Chicago - Department of Medicine, University of Texas at Dallas - Kidney Cancer Program, University of Texas at Dallas - Kidney Cancer Program, University of Texas at Dallas - Southwestern Medical Center and University of Texas at Dallas - Quantitative Biomedical Research Center

MacroGenics, Inc., MacroGenics, Inc., MacroGenics, Inc., MacroGenics, Inc., MacroGenics, Inc., MacroGenics, Inc., MacroGenics, Inc., Independent, Bio-ClinPharm Consulting LLC, Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Harvard University - Department of Hematology/Oncology, University of Chicago - Department of Medicine, Providence Cancer Center - Earle A. Chiles Research Institute, START-Midwest, Independent, MacroGenics, Inc., MacroGenics, Inc., MacroGenics, Inc. and MacroGenics, Inc.